Related Experiment Video

Updated: May 31, 2026

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

Recommendation for the use of newly introduced Tdap vaccine in Korea

Kyong Min Choi1, Kyung Hyo Kim, Yae-Jean Kim

  • 1The Committee on Infectious Diseases, the Korean Pediatric Society, Korea.

Korean Journal of Pediatrics
|July 9, 2011
PubMed

Insights

The Tdap vaccine, a booster for tetanus and diphtheria, helps reduce pertussis incidence and transmission in adolescents and adults. Two Tdap vaccines are approved in Korea for individuals aged 11-64.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Vaccinology

Background:

  • Pertussis, or whooping cough, is a respiratory infection with a characteristic cough.
  • Vaccination with DTwP/DTaP has reduced pertussis, yet outbreaks persist in infants, adolescents, and adults.
  • Rising pertussis cases led to the development of the Tdap vaccine for older age groups.

Purpose of the Study:

  • To summarize recommendations for Tdap vaccine use in Korea.
  • To address the resurgence of pertussis in specific populations.

Main Methods:

  • Review of recommendations from the Korean Pediatric Society's Committee on Infectious Diseases.
  • Identification of approved Tdap vaccines in Korea.

Main Results:

  • Two Tdap vaccines, ADACEL™ and BOOSTRIX®, are approved in Korea.
  • These vaccines are indicated for individuals aged 11-64.

Conclusions:

  • Tdap vaccination is recommended for adolescents and adults to control pertussis.
  • The approved vaccines aim to decrease pertussis incidence and transmission in Korea.

Keywords:
PertussisTdap vaccine

More Related Videos

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo11:17

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo

Published on: August 11, 2018

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Related Concept Videos

Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Vaccinations01:51

Vaccinations

Overview
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...